Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06569121 · ClinicalTrials.gov registry record · NA
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
A NA study of Stroke and Stroke, Acute, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 1
- Study location
NCT06569121: Recruiting NA study of Stroke and Stroke, Acute, sponsored by Baylor Research Institute.
NCT06569121 is a NA study of Stroke and Stroke, Acute that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 94 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06569121, a NA study of Stroke and Stroke, Acute, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.
Primary Outcome
Body weight (lbs) will be captured via self-weighing using provided BodyTrace Smart Scale, which includes cellular connectivity so weight will be sent directly to the research team. The scales have demonstrated good concordance rates with self-weighing in previous research. Scales will be setup by the research team before being mailed to participants with instructions.
Conditions Studied
Interventions
- BEHAVIORAL Group Lifestyle Balance for People Post Stroke (GLB-CVA)
Study Locations (1)
Texas
- Baylor Scott & White Research Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2024-12-07 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT06569121 shows while recruiting
NCT06569121 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Group Lifestyle Balance for People Post Stroke (GLB-CVA) is the first listed.
NCT06569121 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06569121 about?
NCT06569121 is a clinical study titled "Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)". Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.
What is the current status of trial NCT06569121?
This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2024-12-07. Estimated completion is 2029-12-31.
What conditions does trial NCT06569121 study?
This clinical trial studies the following conditions: Stroke, Stroke, Acute, Stroke, Cardiovascular, Stroke/Brain Attack, Stroke (CVA) or TIA.
What interventions are being tested in trial NCT06569121?
The interventions under investigation include: Group Lifestyle Balance for People Post Stroke (GLB-CVA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06569121?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06569121 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06569121's enrollment target sits among peer trials
94 151st of 454 higher than 304 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI